The price of Homology Medicines Inc (NASDAQ: FIXX) closed at $0.90 in the last session, up 0.52% from day before closing price of $0.90. In other words, the price has increased by $+0.0047 from its previous closing price. On the day, 569288 shares were traded.
Ratios:
We take a closer look at FIXX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.25 and its Current Ratio is at 7.25. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on July 28, 2023, Downgraded its rating to Neutral and sets its target price to $1.50 from $9 previously.
On February 22, 2022, BTIG Research reiterated its Neutral rating and also upped its target price recommendation from $35 to $29.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 09 ’24 when TZIANABOS ARTHUR sold 13,037 shares for $0.57 per share. The transaction valued at 7,445 led to the insider holds 128,778 shares of the business.
Alloway Paul sold 7,280 shares of FIXX for $4,120 on Jan 03 ’24. The insider now owns 28,036 shares after completing the transaction at $0.57 per share. On Jan 03 ’24, another insider, Michaud Charles Jr, who serves as the insider of the company, sold 1,708 shares for $0.57 each. As a result, the insider received 975 and left with 11,598 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FIXX now has a Market Capitalization of 52.09M and an Enterprise Value of -29.25M. For the stock, the TTM Price-to-Sale (P/S) ratio is 45.35 while its Price-to-Book (P/B) ratio in mrq is 0.72. Its current Enterprise Value per Revenue stands at -25.30 whereas that against EBITDA is 0.32.
Stock Price History:
Over the past 52 weeks, FIXX has reached a high of $1.48, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is 0.7629, while the 200-Day Moving Average is calculated to be 0.9123.
Shares Statistics:
According to the various share statistics, FIXX traded on average about 377.99K shares per day over the past 3-months and 242.98k shares per day over the past 10 days. A total of 58.02M shares are outstanding, with a floating share count of 42.03M. Insiders hold about 27.70% of the company’s shares, while institutions hold 22.95% stake in the company. Shares short for FIXX as of Feb 29, 2024 were 338.72k with a Short Ratio of 0.90, compared to 315.38k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.58% and a Short% of Float of 0.65%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.23, while EPS last year was -$0.5. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.69 and -$0.69 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
